ׯÏйÙÍø

EN
EN
  • ÒµÎñ×Éѯ

    Öйú£º

    Email: marketing@medicilon.com.cn

    ÒµÎñ×ÉѯרÏߣº400-780-8018

    £¨½öÏÞЧÀÍ×Éѯ£¬ÆäËûÊÂÒËÇ벦´ò´¨É³×ܲ¿µç»°£©

    ´¨É³×ܲ¿µç»°: +86 (21) 5859-1500

    ÍâÑó£º

    +1(781)535-1428(U.S.)

    0044 7790 816 954 (Europe)

    Email:marketing@medicilon.com

ÔÚÏßÁôÑÔ¡Á
µã»÷Çл»
Ò©Îï·¢Ã÷
Drug discovery
Ò©Îï·¢Ã÷

øѧºÍ·Ö×ÓÏ໥×÷ÓÃ

ÉϺ£×¯ÏйÙÍøµÄÉúÎﲿÔÚÌåÍâÉúÎïѧÁìÓòÓµÓи»ºñµÄ¾­Ñ飬ͨ¹ýøˮƽ²â¶¨¡¢Ï¸°ûˮƽ²â¶¨¡¢Ï¸°ûÉúÎïѧ¡¢ÉúÎﻯѧ¡¢ÌåÍâͬλËزⶨ¡¢Îȶ¨Ï¸°ûÖ꽨Á¢¡¢»ùÒòÇóý¡¢RNAiºÍMicroRNA¼¼ÊõµÈ£¬ÌṩһÌ×ÍêÕûµÄÉúÎïѧЧÀÍ¡£

DownloadÎĵµÏÂÔØ
ServicesЧÀÍÏîÄ¿
¼ì²âЧÀÍ
ЧÀÍÏêϸ½éÉÜ
  • Ó«¹âÆÊÎöÒªÁ죺Lanthascreen; Alphascreen; Z¡¯-LYTE; HTRF,TR-FRET,FP µÈ·¢¹âÆÊÎöÒªÁ죺Kinase-Glo; ADP-Glo µÈ;ÎüÊÕ¹âÆÊÎöÒªÁ죺UV; VI;·Ç±ê¼ÇɸѡҪÁ죺SPR£¨Biacore£©¡£
  • ¼¤Ã¸É¸Ñ¡Æ½Ì¨
    øѧ»¥×÷ɸѡƽ̨
    PDE¼Ò×åÂÑ°×øÆäËü
    PDE1AThrombinAR
    PDE1BFVIIaBcl-xl
    PDE2AFIXaBRD4
    PDE3AFxaCathepsin
    PDE4A1FXIaCox1
    PDE4B2FXIIaCox2
    PDE4C1TrypsinER
    PDE4D3PlasminFTO
    PDE5A1TPAHDAC1
    PDE6CUrokinaseHDAC2
    PDE7AKallikernHDAC3
    PDE8AChymotrypsinHDAC4
    PDE10A1TAFIaHDAC5
    HDAC6
    HDAC8
    HIF-1a
    HIF-2a
    HSP90
    Kras-WT
    Kras-G12C
    Kras-G12D
    PARP1
    PARP2
    PHD1
    PHD2
    PHD3
    PPAR¦Á
    PPAR¦Ã
    PPAR¦Ä
    ROR
    ROS
    RYR
    SHP2
    Tubulin
    polymerization
    Tyrosinase
    WRN
    XO
    H+K+ATPase
·Ö×ÓÏ໥×÷ÓÃƽ̨
  • SPR¼¼Êõ¼ò½é
    SPR¡¢ÍâòµÈÀë×ÓÌå¹²Õñ¡¢Í¨¹ýÎïÀí¹âѧЧӦÀ´½ÒʾÂÑ°×ÖÊÒÔ¼°ÆäËûÉúÎï·Ö×ÓÖ®¼äµÄÏ໥×÷Óã¬×ÊÖú¿Í»§Á˽â·Ö×ÓÐÔÄÜ¡¢É¸Ñ¡ÓÐЧ·Ö×Ó¡£¿ÉÌæ´ú²¢ÓÅÓÚÖîÈçWB/Elisa/CO-IP-/Pull-down/ChIP/EMSA/FRET/½Íĸ˫ÔÓ½»µÈÊÔÑé¡£
    Biacore 8K
    Biacore 8K×÷Ϊ¸ßͨÁ¿²âÊÔϵͳ£¬¿ÉÒÔÔÚ¶Ìʱ¼äÄÚ×ÊÖú¿Í»§½øÐдó×ÚµÄÑùÆ·ÆÊÎö¡£×¯ÏйÙÍøÉúÎﲿÅ䱸ÓÐÏȽøµÄÒÇÆ÷Biacore 8KºÍ¾­Ñ鸻ºñµÄÍŶÓÀ´×ÊÖúÄúÍê³ÉSPR²âÊÔ¡£
    Ò»Ì廯£º´Óɸѡµ½±íÕ÷£¬Ò»Ì廯½â¾ö¼Æ»®¡£¸ßͨÁ¿£ºÒ»ÌìÄÚÖÁÉÙ¿Éɸѡ2300¸öÑùÆ·£¬5Сʱ¿ÉÍê³É64¶Ô¶¯Á¦Ñ§±íÕ÷¡£¸ßÁéÃô¶È£º×ÝÈ»ÊÇС·Ö×Ó»ò¸´ºÏÌå°Ðµã£¬Í¬ÑùÄܹ»»ñµÃ¸ßÖÊÁ¿Êý¾Ý£¬³¬¸ßÇ׺ÍÁ¦·Ö×ӵĽâÀëËÙÂʾ«È·±íÕ÷¡£
  • Ó¦ÓùæÄ£
    С·Ö×ÓÒ©Îïɸѡ»úÌ幦ЧÆÀ¼ÛÉúÎï´ó·Ö×Ó×÷ÓÃÁ¦¼ì²âÆäËû¼ì²â
  • ¼ì²âÖ¸±ê
    ½áºÏÌØÒìÐÔÆÊÎö¶¯Á¦Ñ§ÆÊÎöŨ¶ÈÆÊÎöÇ׺ÍÁ¦ÆÊÎö
  • ·Ö×Ó»¥×÷ɸѡƽ̨
    PD-1EPHA2IGF-1RPD-L1EPHA3HSAVEGFEPHA4FcRNNectin-1EPHA5FcRINectin-24-1BBFcRIINectin-3SHP2FcRIIINectin-4ATIIIFactor BNECL1EGFRHER2NECL2Gp130TfR1NECL3OX40EPCRNECL4TIGITSTAT1NECL5FOLR1STAT3EPHA1INSRSTAT5
    øѧ/·Ö×Ó»¥×÷ɸѡƽ̨.jpg
    Figure 1. Nivolumab binding with PD-1
    Figure 2. Novoseven binding with TF
    Figure 3. EFNA1 binding with EphA2
    Figure 4. Novoseven binding with ATIII
    Validated targets£ºPD-1, PD-L1, VEGF, Nectin1, Nectin2, Nectin3, Nectin4, NECL1, NECL2, NECL3, NECL4, NECL5, EPHA1, EPHA2, EPHA3, EPHA4, EPHA5, INSR, IGF-1R, HSA, FcRN, FcRI, FcRII, FcRIII, C1q, Factor B, HER2, Transferrin, EPCR, STAT3, STAT5, STAT1, 4-1BB, SHP2, ATIII, EGFR, gp130
Relevant laboratoriesÏà¹ØʵÑéÊÒ
  • ¸ßËÙÀëÐÄ»ú
  • PCR
  • ø±êÒÇ
  • ѪҺÆÊÎöÒÇ
  • GE-Biacore-8K
  • ø±êÒÇ
  • MEGAROBO-Elisa-Ï´°å»ú
  • Biology-Real-time-PCR
  • ÅàÑøÊÒ
  • ϸ°û·¿
  • ϸ°ûÆÆ»µ»ú
  • ÒÆÒºÆ÷
  • ͬλËØ
Ïà¹ØÎÄÕÂÏà¹ØÎÄÕÂ
¡Á
ËÑË÷ÑéÖ¤
µã»÷Çл»
ÍøÕ¾µØͼ
ÓÑÇéÁ´½Ó£º¿­Ê±¹ú¼ÊÓéÀÖÍø  ±ÒÓιú¼Ê»·ÑÇ  k8¿­·¢ÌìÉúÓ®¼Ò  ×ðÁú¿­Ê±ÈËÉú¾ÍÊÇÓ®  Ôƶ¥¹ú¼Ê  pgÉͽðÅ®ÍõÄ£ÄâÆ÷ÔÚÏßÊÔÍæ  ¿­Ê±k88×îР k8¿­·¢ÌìÉúÓ®¼Ò  ÈËÉú¾ÍÊDz©  ¿­·¢ÌìÉúÓ®¼ÒÒ»´¥¼´·¢Ê×Ò³  ´ó·¢Æ½Ì¨  ¿­Ê±×ðÁú¹ÙÍø  aoaÌåÓý¹ÙÍø  AG¿­·¢K8¹ú¼Ê  AG×ðÁú¿­Ê±